NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Quanterix gets FDA EUA status for Simoa SARS-CoV-2 N protein antigen test » Quanterix

Quanterix gets FDA EUA status for Simoa SARS-CoV-2 N protein antigen test

NS Medical Devices is using cookies

The EUA enables the SARS-CoV-2 N protein antigen test to use with nasopharyngeal samples. (Credit: visuals3Dde from Pixabay)

Related Article

How the remote treatment of hypertension could become a standard of care in the near future

RECOMMENDED COMPANIES

MOST READ

How the remote treatment of hypertension could become a standard of care in the near future

Robotic laparoscopy: Is it the future of minimally-invasive surgical procedures?

Scientists create synthetic cell with patterns of division like natural bacteria

What to expect as MD&M and BIOMEDevice join forces for two-day virtual event

Therapeutic bed equal to parental comfort in managing pain in pre-term babies in the NICU

Recommended Whitepaper